Family history of diabetes and pancreatic cancer as risk factors for pancreatic cancer: The PACIFIC study

Cancer Epidemiology Biomarkers and Prevention

Volumn 22, Issue 10, 2013, Pages 1913-1917

  Austin, Melissa A ^a   Kuo, Elena ^c   Van Den Eeden, Stephen K ^e   Mandelson, Margaret T ^a   Brentnall, Teresa A ^b   Kamineni, Aruna ^c   Potter, John D ^a,d,f  

^a Division of Epidemiology Human Genetics Environmental Sciences   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c GROUP HEALTH RESEARCH INSTITUTE   (United States)

^d Fred Hutchinson Cancer Research Center   (United States)

^e DIVISION OF RESEARCH   (United States)

^f MASSEY UNIVERSITY   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; CANCER PATIENT; CANCER RISK; CASE CONTROL STUDY; CONTROLLED STUDY; DIABETES MELLITUS; FAMILY HISTORY; FEMALE; FIRST DEGREE RELATIVE; HEALTH CARE PLANNING; HUMAN; MAJOR CLINICAL STUDY; MALE; PANCREAS ADENOCARCINOMA; PLEIOTROPY; PRIORITY JOURNAL; PROGENY; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR;

AGED; CARCINOMA, PANCREATIC DUCTAL; CASE-CONTROL STUDIES; DIABETES MELLITUS; FAMILY HEALTH; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LOGISTIC MODELS; MALE; PANCREATIC NEOPLASMS; RISK FACTORS; UNITED STATES;

EID: 84886432436     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-13-0518     Document Type: Article

References (24)

1. Seigel R, Naishadham D, Jemal A. Cancer statistics. CA Cancer J Clin 2012;66:10-29.
2. Fesinmeyer MD, Austin MA, Li CI, De Roos AJ, Bowen DJ. Differences in survival by histologic type of pancreatic cancer. Cancer Epidemiol Biomarkers Prev 2005;14:1766-73.
3. Iodice S, Gandini S, Maisonneuve P, Lowenfels AB. Tobacco and the risk of pancreatic cancer: a review and meta-analysis. Langenbecks Arch Surg 2008;393:535-55.
4. Huxley R, Ansary-Moghaddam A, Berrington de Gonzalez A, Barzi F, Woodward M. Type-II diabetes and pancreatic cancer: a meta-analysis of 36 studies. Br J Cancer 2005;92:2076-83.
5. Elena JW, Steplowski E, Yu K, Hartge P, Tobias GS, Brotzman MJ, et al. Diabetes and risk of pancreatic cancer: a pooled analysis from the Pancreatic Cancer Cohort Consortium. Cancer Causes Control 2013; 24:13-25.
6. Brand RE, Lynch HT. Genotype/phenotype of familial pancreatic cancer. Endocrinol Metab Clin North Am 2006;35:405-15.
7. Klein AP. Genetic susceptibility to pancreatic cancer. Mol Carcinog 2012;51:14-24.
8. Wang W, Chen S, Brune KA, Hruban RH, Parmigiani G, Klein AP. Risk assessment for individuals with a family history of pancreatic cancer. J Clin Oncol 2007;25:1417-22.
9. Permuth-Wey J, Egan KM. Family history is a significant risk factor for pancreatic cancer: results from a systematic review and meta-analysis. Fam Cancer 2009;8:109-17.
10. Jacobs EJ, Chanock SJ, Fuchs CS, LaCroix A, McWilliams RR, Steplowski E, et al. Family history of cancer and risk of pancreatic cancer: a pooled analysis from the Pancreatic Cancer Cohort Consortium. Int J Cancer 2010;127:1421-8.
11. Jacobs EJ, Rodriguez C, Newton CC, Bain EB, Patel AV, Feigelson HS, et al. Family history of various cancer and pancreatic cancer mortality in a large cohort. Cancer Causes Control 2009;20: 1261-9.
12. Pannala R, Leirness JB, Bamlet WR, Basu A, Petersen GM, Chari ST. Prevalence and clinical profile of pancreatic cancer-associated diabetes mellitus. Gastroenterology 2008;134:981-7.
13. Silverman DT, Schiffman M, Everhart J, Goldstein A, Lillemoe KD, Swanson GM, et al. Diabetes mellitus, other medical conditions and familial history of cancer as risk factors for pancreatic cancer. Br J Cancer 1999;80:1830-7.
14. Fesinmeyer MD, Stanford JL, Brentnall TA, Mandelson MT, Farin FM, Srinouanprachanh S, et al. Association between the peroxisome proliferator- activated receptor gamma Pro12Ala variant and haplotype and pancreatic cancer in a high-risk cohort of smokers: a pilot study. Pancreas 2009;38:631-7.
15. Tang H, Dong X, Hassan M, Abbruzzese JL, Li D. Body mass index and obesity- and diabetes-associated genotypes and risk for pancreatic cancer. Cancer Epidemiol Biomarkers Prev 2011;20:779-92.
16. Breslow NE, Day NE. Unconditional logistic regression for matched sets. In: Davis W, editor. Statistical methods in cancer research. Lyon, France: International Agency for Research on Cancer, IARC Scientific Publication No. 32;1980. p. 192-246.
17. Burns DM, Lee L, Shen LZ, Gilpin E, Golley HD, Vaughn J, Shanks TG. Chapter 2. Cigarette smoking behavior in the United States. In: Smoking and Tobacco Control Monograph No. Bethesda, MD: National Cancer Institute: 1997. [accessed 2012 Dec 19]. Available from: http:// cancercontrol.cancer.gov/tcrb/ monographs/8/m8-2.pdf.
18. Pierce BL, Austin MA, Ahsan H. Association study of type 2 diabetes genetic susceptibility variants and risk of pancreatic cancer: an analysis of PanScan-I data. Cancer Causes Control 2011;22:877-83.
19. Hemminki K, Li X. Familial and second primary pancreatic cancers: a nationwide epidemiologic study from Sweden. Int J Cancer 2003;103: 525-30.
20. Amundadottir L, Kraft P, Stolzenberg-Solomon RZ, Fuchs CS, Petersen GM, Arslan AA, et al. Genome-wide association study identifies variants in the ABO locus associated with susceptibility to pancreatic cancer. Nat Genet 2009;41:986-90.
21. Wolpin BM, Chan AT, Hartge P, Chanock SJ, Draft P, Hunter DJ, et al. ABO blood group and the risk of pancreatic cancer. J Natl Cancer Inst 2009;101:424-31.
22. Petersen GM, Amundadottir L, Fuchs CS, Kraft P, Stolzenberg-Solomon RZ, Jacobs KB, et al. A genome-wide association study identified pancreatic cancer susceptibility loci on chromosomes 13q22.1, 1q32.1, and 5p15.33. Nat Genet 2010;42:244-28.
23. WuC, Kraft P, Stolzernberg-Solomon R, Steplowski E, Brotzman M, Xu M, et al. Genome-wide association study of survival in patients with pancreatic adenocarcinoma. Gut. 2012 Nov 24. [Epub ahead of print].
24. Yang J, Benyamin B, McEvoy BP, Gordon S, Henders AK, Nyholt DR, et al. Common SNPs explain a large proportion of the heritability for human height. Nat Genet 2010;42:565-9.